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The aetiology behind odor-related chronic somatic symptoms (O-RCSS) is unknown, 
although both immunological and psychiatric causes have been suggested. The aim of this 
study was to investigate the occurrence of self-reported asthma and hay fever and psychiatric 
symptoms in individuals having O-RCSS compared to individuals with similar chronic 
somatic symptoms (CSS) which were not odors-related, and also compared to healthy 
controls.  
Data from the Hordaland Health Study were used. 13,799 individuals, 40-45 years, 
answered a questionnaire including 16 questions related to somatic symptoms. They also 
indicated if the symptoms were odor-related, and answered questions about asthma and hay 
fever. Anxiety and depression were measured with the Hospital Anxiety and Depression 
Scale.  
38 (0.6%) men and 106 (1.4%) women had O-RCSS, whereas 88 (1.5%) men and 192 
(2.5%) women had CSS. Adjusted logistic regression analyses showed increased odds of self-
reported asthma in those with O-RCSS compared to those with CSS (males: 3.81, 1.06-13.8, 
females: 2.60, 1.05-6.93) and compared to male and female controls (3.56, 1.89-6.68 and 
4.81, 1.92-12.1 respectively). Increased odds of self-reported hay fever were in addition seen 
in females with O-RCSS. There were no differences in psychiatric symptoms between 
individuals with O-RCSS and CSS, although individuals in both groups showed increased 
odds compared to male and female controls.  
Increased occurrence of self-reported asthma was exclusively found among male and 
females with O-RCSS, compared to CSS and controls. Increased occurrence of psychiatric 
symptoms was seen both in individuals with O-RCSS and CSS.  
 




We are daily surrounded by different odors. Some 
odors are attractive while others are disgusting. The 
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ability to smell is important and useful, for instance to 
avoid dangerous situations as fire and poison, but also 
to enjoy food. However, some individuals develop 
severe chronic somatic symptoms in multiple organ 
systems which they relate to exposure to specific 
 
Bergen, Kalfarveien 31, NO-5020, Norway. Tel: (+47) 55 58 61 21, 
Fax: (+47) 55 58 61 30, E-mail: hilde.gundersen@isf.uib.no 
 
H. Gundersen, et al. 
20/ Iran J Allergy Asthma Immunol, Winter 2015                            Vol. 14, No. 1, February 2015 
Published by Tehran University of Medical Sciences (http://ijaai.tums.ac.ir) 
common odors, a condition often referred to as multiple 
chemical sensitivity (MCS).
1
 This condition refers to 
recurrent, self-reported severe symptoms from multiple 
organ systems. The symptoms relate to exposure to a 
wide range of chemically unrelated substances at levels 
normally considered non-toxic. Frequently reported 
symptom-eliciting agents include perfume, exhausts, 
cleaning agents, freshly printed papers, and smoke.
1
 In 
the scientific literature, also other terms of this 
condition have been used, such as idiopathic 
environmental intolerance, chemical intolerance, 
chemical sensitivity, and sensitivity-related intolerance. 
Previous studies have shown different degrees of 
chemical sensitivity, ranging from mild chemical 
annoyance to disabling odor-related chronic somatic 
symptoms. Depending on the definitions, prevalences 
of chemical sensitivity between 9-33% have been 
reported in the general population.
2-4
 For disabling 
odor-related chronic somatic symptoms prevalences 
have varied between 0.5% and 6.3%.
4-7
 Women report 




The reasons why some individuals evolve odor-
related chronic somatic symptoms is unknown. There  
is no conventional toxicological dose-response 
relationship between the odor concentration and  
the occurrence of the symptoms. The symptoms are 
almost exclusively non-specific, cannot be linked to 
any single organ or laboratory finding, and are also 
frequently reported in the general population.
9-11
 The 
most frequently reported symptoms in individuals 
affected by odor exposure are gastrointestinal 
symptoms, headache, extreme fatigue, muscle and joint 




In a review article, Genuis
12
 showed that there is 
limited scientific literature on the pathogenic 
mechanisms involved in sensitivity-related illnesses. 
Several pathophysiological mechanisms have been 
proposed, such as sensitization, and symptom 
acquirement due to classical conditioning.
13-15
 Double-
blind placebo provocation studies with exposure to 
solvent concentrations below odor threshold found that 
individuals with MCS cannot differentiate active and 
sham exposures.
16
 This finding suggests that 
psychological mechanisms are likely to be a causative 
part of the problem.
17
 Increased levels of psychiatric 
symptoms, such as depression, anxiety, and 
somatization, are frequently reported.
18-20
 On the other 
hand, increased reactivity in the skin and airways upon 




No previous studies have compared the occurrence 
of immunological and psychiatric factors in individuals 
with odor-related somatic symptoms with individuals 
having similar symptoms which are not odor-related. 
We wanted to explore if there was a difference in the 
relationship between immunological factors and odor-
related symptoms compared to psychological factors 
and odor-related symptoms. In order to do so, we 
compared the occurrence of self-reported asthma, hay 
fever, anxiety and depression in individuals with and 
without odor-related chronic somatic symptoms and 
among healthy controls. Asthma and hay fever were 
chosen as these diseases may be caused by 
immunological mechanisms. Anxiety and depression 
represented psychological diseases. 
 
MATERIALS AND METHODS 
 
The Hordaland Health Study 1997–1999 (HUSK), 
Norway, was conducted as collaboration between the 
National Health Screening Service, the University of 
Bergen and local health services. The study protocol 
was approved by the Regional Committees for Medical 
and Health Research Ethics in Western Norway (REK-
Vest) and by the Norwegian Data Inspectorate, and 
informed consent was collected for all participants. 
Health information used in this study was self-reported 
from the HUSK questionnaire. 
 
Base Study Population  
The base population included 29,395 individuals 
residing in Hordaland County, born between 1953 and 
1957, aged between 40–45 years at the time. A total of 
18,581 (8,598 men and 9,983 women) answered the 
basic questionnaire yielding a response rate of 63%. 
Only individuals who answered sixteen questions 
regarding somatic symptoms, and the single question 
whether the symptoms were odor-related, and questions 
about asthma, hay fever and psychiatric symptoms (see 
below) were included in the analyses, totally 13,799 
individuals (6,007 men and 7,792 women). 
 
Chronic Somatic Symptoms 
Somatic symptoms in five organ systems were 
measured by sixteen questions, using a five-point scale 
(range: almost never, seldom, sometimes, often, and 
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almost always). Six questions were related to gastro-
intestinal symptoms (abdominal pain, nausea, feeling 
bloated or full of gas, bad taste in mouth, or excessively 
coated tongue, complaints of vomiting or regurgitation 
of food, and complaint of frequent and loose motions of 
discharge off fluids from anus), two questions were 
related to cardiovascular symptoms (breathlessness 
without exertion, and chest pains), two questions were 
related to genito-urinary symptoms (dysuria or 
complaints of frequency of micturition, and unpleasant 
sensations in or around the genitals), and three 
questions were related to skin and pain symptoms 
(complaints of blotchiness or discoloration of the skin, 
pain in the limbs, extremities or joints, and unpleasant 
numbness or tingling sensation). These 13 questions 
were obtained from the ICD-10 symptom criteria of 
somatization disorder (ICD-10, F45.0). In addition 
three questions were related to CNS symptoms 
(headache, dizziness, and marked tiredness). 
Subsequently, the individuals answered one 
question regarding odor sensitivity: “do you experience 
any of the somatic symptoms above when you are 
exposed to smell of perfume, cooking smell, or exhaust 
or something similar?” (yes/no).  
Participants were divided into three groups for the 
statistical analysis. Group 1 consisted of individuals 
with odor-related chronic somatic symptoms (O-RCSS) 
(i.e. individuals that almost always experienced somatic 
symptoms in at least two different organ systems, and 
confirmed that the symptoms were odor-related). 
Group 2 consisted of individuals with chronic somatic 
symptoms (CSS), which were not-odor-related (i.e. 
individual that almost always experienced somatic 
symptoms in at least two different organ systems, and 
confirmed that the symptoms were not odor-related). 
The third group (controls) were individuals not 
included in the two above mention groups (O-RCSS or 
CSS). 
 
Asthma, Hay Fever, Anxiety and Depression 
Information about former or present asthma (yes or 
no) and hay fever (yes or no) were obtained from the 
HUSK questionnaire. Psychiatric symptoms during the 
last week were measured with The Hospital Anxiety 
and Depression Scale (HADS).
22
 HADS consists of 14 
items, seven related to anxiety (HADS-A) and seven to 
depression (HADS-D). All items were scored on a 
four-point scale from 0 to 3. The scale has shown good 
psychometric properties
22,23 
Symptoms of severe 
psychopathology were not included in the scale, which 
makes HADS more sensitive to milder 
psychopathology. Cut off scores of ≥ 8 were used to 
identify individuals with anxiety (HADS-A ≥ 8), 
depression (HADS-D ≥ 8) or comorbid anxiety and 
depression (both HADS-A and HADS-D ≥ 8)
24
 HADS 
was used as a categorical variable with normal score as 
the reference.  
 
Background Variables 
Variables like educational level, occupation during 
the past twelve months, smoking habits, weekly 
physical activity, chronic diseases, house pet keeping 
(cat or dog), and use of medication were obtained from 
the HUSK questionnaire, and used as descriptive 
variables or as adjusting variables in the statistical 
analysis.  
Education was categorized into five levels in the 
questionnaire, but regrouped into two levels in the 
statistical analyses; lower education (up to upper 
secondary school) and higher education (University and 
University College). 
Occupation during the past twelve months was 
entered as free text by the participants. These 
occupations were assigned a four-digit numerical code 
in accordance with the International Standard 
Classification of Occupations (ISCO-88) by a trained 
person. In the statistical analyses, occupations were 
divided into two categories based on assumed levels of 
exposures to dust and gases: occupations with low 
exposure and occupations with high exposure. Two 
hundred and fifty-one occupations were assigned to 
low exposure and 53 to high exposure.  
Smoking habits were sorted into two categories for 
the analyses: non-smokers (including both those who 
had never smoked and ex-smokers), and current 
smokers. Ex-smokers were defined as individuals who 
had stopped smoking more than one year before the 
survey, while current smokers had smoked daily for 
more than one year.  
Individuals estimated weekly physical activity as 
follows: no physical activity, one hour a week, two 
hours a week and three or more hours a week.  
Body mass index (BMI) (kg/m
2
) was calculated 
based on height and weight obtained from the clinical 
examination. BMI was categorized into four levels 
using the World Health Organization’s system: 
underweight (BMI< 18.5kg/m
2
), normal weight (BMI ≤ 
18.5-24.9 kg/m
2
), overweight (BMI ≤ 25.0 – 29.9 
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kg/m
2
) and obese (BMI > 30kg/m
2
).  
Individuals indicated the presence or absence 
(yes/no) of chronic diseases as multiple sclerosis, 
diabetes mellitus, angina pectoris, heart attacks and 
strokes. Individuals who at any time in their life have 
had one or more of the above-mentioned 
diagnoses/diseases were defined as an individual 
having a chronic disease.  
Daily or almost daily use of medication during the 
last year was reported for each of the following: pain 
killers, sedatives, anti-depressants, allergy medications 
and asthma medication. In our analyses, we only 
distinguished between use and no use of such 
medication during the last year.  
 
Statistical Analyses  
The Statistical Products of Service Solution 
package (SPSS Statistics, version 19) was used for all 
statistical analyses. Crosstables and Pearson Chi-square 
tests were used to compare categorical variables in the 
three groups (O-RCSS, CSS and controls). Two series 
of logistic regression analyses were used to examine 
the association between having O-RCSS or CSS and 
asthma, hay fever, anxiety, depression and comorbid 
anxiety and depression. In the first model, individuals 
with O-RCSS and CSS where included with healthy 
controls as reference group. In the second model, 
individuals with O-RCSS were explored when 
individuals with CSS served as reference group. In both 
models we adjusted for educational level, occupational 
exposure to dust and gases, smoking habits, house pets, 
levels of physical activity, BMI and presence or 
absence of chronic diseases. All analyses were 
separated by sex. Since we have a narrow age range 
(40-45 years), we did not adjust for age. P-value of 




In the present study population, O-RCSS were 
found in 0.6% (n=38) of the men and in 1.4% (n=86)  
of the women, whereas CSS were seen in 1.5% (n=106) 
of the men and in 2.5% (n=192) of the women (Table 
1).  
Women with O-RCSS had lower education, were 
less physical active, had higher BMI, smoked more and 
had higher occurrence of chronic diseases than female 
controls (Table 1). In addition they used more 
painkillers, sleep medicine, sedatives, antidepressants, 
and allergy and asthma medicine than the controls. 
There were no significant differences in occupational 
exposure to dust and gases or in exposure from house 
pets between the two groups.  
Women with O-RCSS had significantly higher 
education and BMI compared to women with CSS 
(Table 1). They used significantly more pain killers and 
allergy and asthma medicine, but there were no 
differences in use of sleep medicine, sedatives or 
antidepressants. There were no significant differences 
between the two groups in smoking habits, levels of 
physical activity, occurrence of chronic diseases, 
occupational exposure to dust and gases or in house 
hold pets. 
Men with O-RCSS had significantly lower 
education, were less physical active, had occupations 
with more exposure of dust and gases and had more 
house pets than male controls (Table 1). They used 
more pain killers, sleep medicine, sedatives, 
antidepressants and asthma medicine, but there were no 
significant differences in use of allergy medicine 
compared to male controls. There were also no 
differences in smoking habits, BMI and in occurrence 
of chronic diseases between the two groups. Men with 
O-RCSS were significantly more physically active and 
reported more use of asthma medicine compared to 
men with CSS. There were no significant differences 
between the two groups in the other background 
variables. 
 
Asthma, Hay Fever, Anxiety and Depression in 
Individuals with O-RCSS and CSS vs. Controls 
Logistic regression analyses adjusted for educational 
level, occupational exposure, smoking habits, levels of 
physical activity, BMI and presence of chronic diseases 
showed that women with O-RCSS had significantly 
higher odds ratio (OR) of asthma, high fever, anxiety 
and comorbid anxiety and depression compared to 
female controls (Table 2). 
Women with CSS had significantly higher OR of 
anxiety, depression and comorbid anxiety and 
depression compared to female controls (Table 2). A 
similar analysis for men showed significantly OR of 
asthma and comorbid anxiety and depression in those 
with O-RCSS compared to male controls. Men with 
CSS had significantly higher OR only of anxiety and 
comorbid anxiety and depression. 
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Table 1. Prevalence and significant levels in women and men with odor-related chronic somatic symptoms (O-RCSS), in 
women and men with chronic somatic symptoms which are not odor-related (CSS), and in healthy female and male controls. 
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a) **, c) * 
a)Significant levels for comparisons between O-RCSS and controls b)Significant levels for comparisons between CSS and controls c)Significant levels 
for comparisons between O-RCSS and CSS., *p <.05, **p <.01 
 
Asthma, Hay Fever, Anxiety and Depression in 
Individuals with O-RCSS vs. CSS 
Logistic regression analyses adjusted for potential 
covariates indicated that women with O-RCSS had 
significantly higher OR of asthma and high fever 
compared to women with CSS (Table 3). There were no 
significant differences in levels of anxiety, depression 
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Table 2. Odds ratio (OR) and 95 % CI of self-reported asthma, hay fever, anxiety, depression and comorbidity of anxiety and 
depression in women and men with odor-related chronic somatic symptoms (O-RCSS) and chronic somatic symptoms (CSS) 












Asthma 22% 3.56 (1.89-6.68) 7.9% 1.51 (0.80-2.86) 6.4% 
Hay fever 33% 2.72 (1.58-4.68) 17% 0.94 (0.55-1.61) 15% 
Anxiety 26% 3.08 (1.79-5.29) 26% 2.85 (1.91-4.27) 14% 
Depression 3.8% 1.08 (0.26-4.49) 5.8% 2.48 (1.17-5.26) 2.4% 
Comorbidity 34% 5.89 (3.27-10.6) 27% 4.99 (3.17-7.86) 5.5% 
Men (n=38) OR (95%CI) (n=88) OR (95%CI) (n=5881) 
Asthma 24% 4.81 (1.92-12.1) 10% 1.77 (0.75-4.14) 5.3% 
Hay fever 29% 1.89 (0.80-4.50) 12% 0.71 (0.34-1.50) 16% 
Anxiety 13% 2.05 (0.77-5.44) 18% 2.26 (1.22-4.18) 9.4% 
Depression 7.9% 1.33 (0.31-5.73) 11% 2.05 (0.92-4.57) 4.8% 
Comorbidity 37% 7.18 (3.17-16.3) 29% 5.05 (2.85-8.94) 6.4% 
 
Table 3. Odds ratio (OR) and 95 % CI of self-reported 
asthma, hay fever, anxiety, depression and comorbidity of 
anxiety and depression in women and men with odor-
related chronic somatic symptoms (O-RCSS) after 
adjusting for possible confounders. Men and women with 
similar chronic somatic symptoms that are not odor-
related (CSS) served as reference. 
 Women OR (95% CI) Men OR (95% CI) 
Asthma   2.60 (1.05-6.93) 3.81 (1.06-13.8) 
Hay fever 3.16 (1.44-6.92) 3.47 (0.95-12.6) 
Anxiety 0.94 (0.47-1.87) 0.69 (0.20-2.38) 
Depression 0.34 (0.05-2.14) 0.54 (0.09-3.18) 
Comorbidity 1.25 (0.59-2.63) 1.54 (0.53-4.42) 
 
Logistic regression analyses adjusted for potential 
covariates showed that men with O-RCSS  
had significantly higher OR of asthma compared to  
men with CSS (Table 3). There were no significant 
differences in hay fever, levels of anxiety, depression and 




Our results showed an association between self-
reported asthma and O-RSCC, as well as between hay 
fever and O-RSCC. Men and women with O-RCSS had 
significantly higher prevalence of self-reported asthma 
compared with men and women with CSS, and 
compared with male and female controls.  
 
In addition women with O-RCSS had a higher 
prevalence of self-reported hay fever. There was no 
significant difference in the levels of anxiety and 
depression between individuals with O-RCSS and CSS, 
although the levels in both groups were higher than in 
controls. 
Our results may support the hypothesis that 
immunological factors are involved in the pathogenesis 
of odor-related chronic somatic symptoms. Asthma and 
hay fever are of course only a kind of proxy for 
immunological diseases in the present study, but the 
relationship between these diseases and O-RSCC is 
clear in the present analyses. Immunological changes 
have been suggested by numerous authors as the 
pathogenesis of odor-related chronic somatic 
symptoms. De Luca and colleagues suggested odor-
related somatic symptoms to be due to immunological 
and biochemical disturbances 
25
, and to chronic 
oxidative stress 
26
. Furthermore a dose-dependent non-
immunological IgE mediated release of histamine from 
peripheral blood basophils has been shown after 
perfume exposure.
27
 It has also been suggested that 
chemical sensitivity might result from bonding of low 
molecular weight chemical compounds to 
chemoreceptors on sensory nerve C-fibres which leads 
to release of inflammatory mediators.
28
 
Our findings are in line with previous studies in 
general populations that have reported associations 
between odor-related somatic symptoms and asthma.A 
telephone survey in North Carolina including 1027 
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individuals showed that simultaneous allergy and 
chemical sensitivity were reported by 16.9% of the 
population.
4
 Similarly, Kreutzer and colleagues
6
 
showed an association between asthma and allergic 
reactions and chemical intolerance in a population 
based survey from California including 4046 
individuals. Furthermore, population study from US, 
including 1058 individuals, showed an association 





 found that among those 
diagnosed with MCS, 42% also reported to have been 
diagnosed with asthma.  
In another study, 20.3% of patients from two 
primary care clinics met the criteria for chemical 
intolerance according to the Quick Environmental 
Exposure and Sensitivity Inventory questionnaire. 
Individuals with chemically intolerance reported 
significantly higher rates of comorbid allergies and 
they more often met criteria for possible major 
depressive disorder, panic disorder, generalized anxiety 




Our results also showed that there were no 
significant differences in anxiety and depression 
symptoms between individuals with CSS and O-RCSS, 
indicating that psychiatric symptoms were not only 
present for those with O-RCSS. However, compared to 
male and female controls, higher prevalences of anxiety 
and depression were reported in both groups. These 
findings are in accordance with previous studies 
showing that individuals with odor-related somatic 
symptoms had higher level of anxiety and depression 
compared to controls.
20,31-33
 In a recent PET study, 
Hillert and colleagues
34
 reported evidence that harm 
avoidance is an important part of the aetiology of MCS. 
Classical conditioning,
15
 expectancy of severe somatic 
symptoms related to odor-exposure,
35
 and panic 
disorder in relation to odor-exposure
36
 have been 
suggested as possible explanations of odor-related 
chronic somatic symptoms. 
The present study indicates no relationship between 
O-RCC and anxiety or depression. This is in line with 
findings of Caress and colleagues
37
 who showed that 
only 1.4% of individuals with odor-related symptoms 
had a history of prior emotional problems before odor-
related somatic symptoms evolved. However, Caress 
and colleagues also showed that 38% developed 
emotional problems after appearance of physical 
symptoms. This is not supported by our present study. 
However, our methods were different and we have no 
knowledge about when the different symptoms started. 
Also, another case-control study has suggested that 
individuals with chemical intolerance have a history of 




This study has several limitations. The cross-
sectional design makes it difficult to establish any 
causality between asthma, hay fever and O-RCSS. 
However, results from the regression analyses  
do support an association between these factors.  
The present study are based upon self-reports only, and 
has no objective measures of asthma or hay fever. 
However, previous studies have suggested  
an association between self-reports of these diagnoses 
and objective measures of atopy, such as high levels  
of Immunoglobulin E.
39
 Several other questions and 
test could have been added to improve the present 
study. However, one of the strengths was that the 
questions were asked in the frame of a larger study with 
main focus on other disorders and complaints than O-
RCSS. This may have increased the validity of our 
results. 
Our results showed that individuals with O-RCSS 
and CSS had lower scores than male and female 
controls on indicators on health, lifestyle and 
socioeconomic status. This is also seen in other 
studies.
31
 In this study we controlled for such factors by 
appropriate statistical methods. 
In conclusion, odor-related chronic somatic 
symptoms in multiple organ systems are associated 
with self-reported asthma, hay fever, anxiety and 
depression. Chronic somatic symptoms which are not 
odor-related, are associated with self-reported anxiety 
and depression, but not with self-reported asthma and 
hay fever. The results support that immunological 
factors may be involved in the pathogenesis of odor-
related somatic symptoms, although we cannot exclude 
that also psychiatric factors contribute. Future studies 
on this topic should be performed, including both 





1. Cullen MR. Multiple chemical sensitivities: summary and 
 directions for future investigators. Occup Med 1987; 
2(4):801-4. 
H. Gundersen, et al. 
26/ Iran J Allergy Asthma Immunol, Winter 2015                            Vol. 14, No. 1, February 2015 
Published by Tehran University of Medical Sciences (http://ijaai.tums.ac.ir) 
2. Hausteiner C, Mergeay A, Bornschein S, Zilker T, Forstl 
H. New aspects of psychiatric morbidity in idiopathic 
environmental intolerances. J Occup Environ Med 2006; 
48(1):76-82. 
3. Caress SM, Steinemann AC. A national population study 
of the prevalence of multiple chemical sensitivity. Arch 
Environ Health 2004; 59(6):300-5. 
4. Meggs WJ, Dunn KA, Bloch RM, Goodman PE, 
Davidoff AL. Prevalence and nature of allergy and 
chemical sensitivity in a general population. Arch 
Environ Health 1996; 51(4):275-82. 
5. Hausteiner C, Bornschein S, Hansen J, Zilker T, Forstl H. 
Self-reported chemical sensitivity in Germany: a 
population-based survey. Int J Hyg Environ Health 2005; 
208(4):271-8. 
6. Kreutzer R, Neutra RR, Lashuay N. Prevalence of people 
reporting sensitivities to chemicals in a population-based 
survey. Am J Epidemiol 1999; 150(1):1-12. 
7. Johansson A, Millqvist E, Nordin S, Bende M. 
Relationship between self-reported odor intolerance and 
sensitivity to inhaled capsaicin: proposed definition of 
airway sensory hyperreactivity and estimation of its 
prevalence. Chest 2006; 129(6):1623-8. 
8. Berg ND, Linneberg A, Dirksen A, Elberling J. 
Prevalence of self-reported symptoms and consequences 
related to inhalation of airborne chemicals in a Danish 
general population. Int Arch Occup Environ Health 2008; 
81(7):881-7. 
9. Rief W, Auer C. Is somatization a habituation disorder? 
Physiological reactivity in somatization syndrome. 
Psychiatry Res 2001; 101(1):63-74. 
10. Rief W, Hessel A, Braehler E. Somatization symptoms 
and hypochondriacal features in the general population. 
Psychosom Med 2001; 63(4):595-602. 
11. Bornschein S, Hausteiner C, Konrad F, Forstl H, Zilker T. 
Psychiatric morbidity and toxic burden in patients with 
environmental illness: a controlled study. Psychosom 
Med 2006; 68(1):104-9. 
12. Genuis SJ. Sensitivity-related illness: the escalating 
pandemic of allergy, food intolerance and chemical 
sensitivity. Sci Total Environ 2010; 408(24):6047-61. 
13. Andersson L, Bende M, Millqvist E, Nordin S. Attention 
bias and sensitization in chemical sensitivity. J 
Psychosom Res 2009; 66(5):407-16. 
14. Devriese S, Winters W, Stegen K, Van Diest I, 
Veulemans H, Nemery B, et al. Generalization of 
acquired somatic symptoms in response to odors: a 
pavlovian perspective on multiple chemical sensitivity. 
Psychosom Med 2000; 62(6):751-9. 
15. Van den Bergh O, Devriese S, Winters W, Veulemans H, 
Nemery B, Eelen P, et al. Acquiring symptoms in 
response to odors: a learning perspective on multiple 
chemical sensitivity. Ann N Y Acad Sci 2001; 933:278-
90. 
16. Bornschein S, Hausteiner C, Rommelt H, Nowak D, 
Forstl H, Zilker T. Double-blind placebo-controlled 
provocation study in patients with subjective Multiple 
Chemical Sensitivity (MCS) and matched control 
subjects. Clin Toxicol (Phila) 2008; 46(5):443-9. 
17. Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical 
sensitivities: A systematic review of provocation studies. 
J Allergy Clin Immunol 2006; 118(6):1257-64. 
18. Black DW. The relationship of mental disorders and 
idiopathic environmental intolerance. Occup Med 2000; 
15(3):557-70. 
19. Hausteiner C, Bornschein S, Bickel H, Zilker T, Forstl H. 
Psychiatric morbidity and low self-attentiveness in 
patients with environmental illness. J Nerv Ment Dis 
2003; 191(1):50-5. 
20. Bailer J, Witthoft M, Paul C, Bayerl C, Rist F. Evidence 
for overlap between idiopathic environmental intolerance 
and somatoform disorders. Psychosom Med 2005; 
67(6):921-9. 
21. Berg ND, Linneberg A, Thyssen JP, Dirksen A, Elberling 
J. Non-allergic cutaneous reactions in airborne chemical 
sensitivity--a population based study. Int J Hyg Environ 
Health 2011; 214(3):239-45. 
22. Zigmond AS, Snaith RP. The hospital anxiety and 
depression scale. Acta Psychiatr Scand 1983; 67(6):361-
70. 
23. Mykletun A, Stordal E, Dahl AA. Hospital Anxiety and 
Depression (HAD) scale: factor structure, item analyses 
and internal consistency in a large population. Br J 
Psychiatry 2001;179:540-4. 
24. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The 
validity of the Hospital Anxiety and Depression Scale. An 
updated literature review. J Psychosom Res 2002; 
52(2):69-77. 
25. De Luca C, Raskovic D, Pacifico V, Thai JC and Korkina 
L. The search for reliable biomarkers of disease in 
multiple chemical sensitivity and other environmental 
intolerances. Int J Environ Res Public Health. 2011; 8(7): 
2770-97. 
26. De Luca C, Scordo MG, Cesareo E, Pastore S, Mariani S, 
Maiani G, Stancato A, Loreti B, Valacchi G, Lubrano C, 
Raskovic D, De Padova L, Genovesi G, Korkina LG. 
Biological definition of multiple chemical sensitivity 
from redox state and cytokine profiling and not from 
polymorphisms of xenobiotic-metabolizing enzymes. 
Toxicol Appl Pharmacol. 2010; 248(3): 285-92. 
27. Elberling J, Skov PS, Mosbech H, Holst H, Dirksen A, 
Johansen JD. Increased release of histamine in patients 
with respiratory symptoms related to perfume. Clin Exp 
Allergy 2007; 37(11):1676-80. 
Odor- related Chronic Somatic Symptoms and Asthma and Hay Fever 
Vol. 14, No. 1, February 2015                                                                                                                                 Iran J Allergy Asthma Immunol, Winter 2015 /27 
Published by Tehran University of Medical Sciences (http://ijaai.tums.ac.ir) 
28. Meggs WJ. Mechanisms of allergy and chemical 
sensitivity. Toxicol Ind Health 1999; 15(3-4):331-8. 
29. Caress SM, Steinemann AC. Asthma and chemical 
hypersensitivity: prevalence, etiology, and age of onset. 
Toxicol Ind Health 2009; 25(1):71-8. 
30. Caress SM, Steinemann AC. National prevalence of 
asthma and chemical hypersensitivity: an examination of 
potential overlap. J Occup Environ Med 2005;47(5):518-
22. 
31. Katerndahl DA, Bell IR, Palmer RF, Miller CS. Chemical 
intolerance in primary care settings: prevalence, 
comorbidity, and outcomes. Ann Fam Med 2012; 
10(4):357-65. 
32. Tonori H, Aizawa Y, Ojima M, Miyata M, Ishikawa S, 
Sakabe K. Anxiety and depressive states in multiple 
chemical sensitivity. Tohoku J Exp Med 2001; 
193(2):115-26. 
33. Papo D, Eberlein-Konig B, Berresheim HW, Huss-Marp 
J, Grimm V, Ring J, et al. Chemosensory function and 
psychological profile in patients with multiple chemical 
sensitivity: comparison with odor-sensitive and 
asymptomatic controls. J Psychosom Res 2006; 
60(2):199-209. 
34. Hillert L, Jovanovic H, Ahs F, Savic I. Women with 
multiple chemical sensitivity have increased harm 
avoidance and reduced 5-HT(1A) receptor binding 
potential in the anterior cingulate and amygdala. PLoS 
One 2013; 8(1):e54781. 
35. Meulders A, Fannes S, Van Diest I, De Peuter S, 
Vansteenwegen D, Van den Bergh O. Resistance to 
extinction in an odor-20% CO2 inhalation paradigm: 
further evidence for a symptom learning account of 
multiple chemical sensitivity. J Psychosom Res 2010; 
68(1):47-56. 
36. Binkley KE, Kutcher S. Panic response to sodium lactate 
infusion in patients with multiple chemical sensitivity 
syndrome. J Allergy Clin Immunol 1997; 99(4):570-4. 
37. Caress SM, Steinemann AC. A review of a two-phase 
population study of multiple chemical sensitivities. 
Environ Health Perspect 2003; 111(12):1490-7. 
38. Simon GE, Daniell W, Stockbridge H, Claypoole K, 
Rosenstock L. Immunologic, psychological, and 
neuropsychological factors in multiple chemical 
sensitivity. A controlled study. Ann Intern Med 1993; 
119(2):97-103. 
39. Bakke JV, Wieslander G, Norback D, Moen BE. Atopy, 
symptoms and indoor environmental perceptions, tear 
film stability, nasal patency and lavage biomarkers in 
university staff. Int Arch Occup Environ Health 2008; 
81(7):861-72.
 
 
